ReviewJournal of rheumatic diseases2021

Safety of Tacrolimus in Autoimmune Disease: Results From Post-marketing Surveillance in South Korea.

Wan-Hee Yoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.